<DOC>
	<DOCNO>NCT02338375</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy add allogenic umbilical cord blood-derived stem cell product ( Cartistem® ) currently standard treatment arthroscopic curettage microfracture osteochondral lesion talus .</brief_summary>
	<brief_title>Safety Efficacy Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product</brief_title>
	<detailed_description />
	<criteria>Nonresponder conservative treatment radiographically confirm ( MRI ) osteochondral lesion talus ankle pain and/or stiffness le 75 AOFAS score Age 20 70 yearold Appropriate function blood clot PT ( INR ) &lt; 1.5 , APTT &lt; 1.5×control Appropriate renal function Creatinine ≤ 2.0 ㎎/㎗ , proteinuria less trace Dipstick urine test Appropriate hepatic function Bilirubin ≤ 2.0 ㎎/㎗ , AST/ALT ≤ 100 IU/L No evidence autoimmue disorder As screen test antinuclear antibody and/or antithyroglobulin antibody , positive rheumatologist referral need confirm diagnosis No surgery radiotherapy ankle joint within 6 week Female patient agree maintenance contraception study period No ligament instability great grade II ( Grade 0 : none , Grade Ⅰ : 0~5㎜ , GradeⅡ : 5~10㎜ , Grade Ⅲ : &gt; 10㎜ ) physical exam Patients agree participation study sign informed consent Degenerative ankle arthritis patient Patients autoimmune disease Patients infectious disease need parenteral antibiotic Patients myocardial infarction , congestive heart failure , serious heart diseases uncontrollable hypertion Patients serious medical illness Pregnancy breast feeding patient Past history relate psychiatric illness epilepsy Alcoholic abuse Heavy smoker Chronic inflammatory disease include rheumatoid arthritis Participants clinical trial within 4 week Patients treat immunosuppressing agent Cyclosporin A azathioprine within 6 week Unstable ankle joint ( lesion site ) great grade II physical exam ( Grade 0 : none , grade Ⅰ : 0~5㎜ , GradeⅡ : 5~10㎜ , Grade Ⅲ : &gt; 10㎜ ) Other inappropriate patient determine prinicipal investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>